E. Ohtaki et al., ACUTE DISSEMINATED ENCEPHALOMYELITIS AFTER TREATMENT WITH JAPANESE B ENCEPHALITIS VACCINE (NAKAYAMA-YOKEN AND BEIJING STRAINS), Journal of Neurology, Neurosurgery and Psychiatry, 59(3), 1995, pp. 316-317
Seven children with acute disseminated encephalomyelitis (ADEM) after
treatment with Japanese B encephalitis vaccine (JBEV) (Nakayama-Yoken
strain 1968-88 and Beijing strain 1989-93) were identified by mailed q
uestionnaires and by compilation of previously published case reports.
It was considered that encephalomyelitis might have been related to v
accine treatment as the vaccine is derived from mouse brain tissue inf
ected with Japanese B encephalitis virus, a potentially cross reactive
antigen. The incidence of severe neurological complications associate
d with the newer Japanese B encephalitis Beijing strain vaccine seemed
to be less than one case per 1 000 000, which is similar to the incid
ence of neurological complications associated with the older Nakayama-
Yoken strain vaccine.